ADVERTISEMENT

Uganda, Tanzania inch closer to hitting the 90-90-90 Hiv/Aids target as Kenya lags behind

A doctor draws blood from a man to check for HIV/AIDS at a mobile testing unit in Ndeeba, a suburb in Uganda's capital Kampala May 16, 2014.
  • According to the US President’s Emergency Plan for Aids Relief (Pepfar), between October 2018 and June last year, 93% of all people living with HIV in Uganda were on the life giving and prolonging antiretroviral therapy (ART).
  • In Tanzania, 86% of all people living with HIV are on ARTs.
  • Kenya’s 5.6% HIV prevalence is the highest in East Africa while Somalia’s 0.3% HIV prevalence is the lowest in Eastern Africa.

Uganda and Tanzania are closer to achieving the ambitious 90-90-90 treatment target to help end the Aids epidemic.

The ‘pearl of Africa’ as Uganda likes to fondly refer to itself leads the East Africa region with the largest percentage of people living with HIV receiving antiretroviral therapy (ART), according to the US President’s Emergency Plan for Aids Relief (Pepfar).

Data from the Department of State’s Co-ordination and Oversight of Pepfar, shows between October 2018 and June last year, 93% of all people living with HIV in Uganda were on the life giving and prolonging ART.

ADVERTISEMENT

In Tanzania, 86% of all people living with HIV were on ARTs compared to 82% of Kenyans living with HIV. Malawi tied with Uganda in the number of all people living with HIV under ARTs.

According to the review, which reviewed Uganda, Kenya, Tanzania and Malawi, Uganda surpassed its second goal of 90:90:90, an ambitious global HIV programme proposed by UNAids and adopted by high prevalence member countries.

90:90:90 targets by 2020, 90% of all people living with HIV know their HIV status, 90% of all people with diagnosed HIV infection receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy have viral suppression.

Why Uganda is ahead of her peers

ADVERTISEMENT

According to Ugandan officials, the country is locally producing generic ARTs, which has seen the cost of these life-saving remedies drop from between $15 and $9 to between $9 and $2 per patient per month.

The latest study shows that the HIV incidence has declined to 5.6%, compared with 8.9% in 2000 following increased usage of ART. Even then, more than one-third of those infected are still not under the ART.

The study indicated Kenya’s 5.6% HIV prevalence is the highest in East Africa. Uganda is second in the region at 5.5% of the population, Tanzania 3.9% and South Sudan at 1.3%. In the larger eastern Africa, Somalia has the lowest prevalence at 0.3% followed by Ethiopia at 0.9%.

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.com.gh

ADVERTISEMENT